These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30213921)

  • 21. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling.
    van der Schee MP; Palmay R; Cowan JO; Taylor DR
    Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia.
    Paff T; van der Schee MP; Daniels JM; Pals G; Postmus PE; Sterk PJ; Haarman EG
    J Cyst Fibros; 2013 Sep; 12(5):454-60. PubMed ID: 23361110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting multiple sclerosis via breath analysis using an eNose, a pilot study.
    Ettema AR; Lenders MWPM; Vliegen J; Slettenaar A; Tjepkema-Cloostermans MC; de Vos CC
    J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33271513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
    Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
    J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time exhaled breath analysis in patients with cystic fibrosis and controls.
    Gaisl T; Bregy L; Stebler N; Gaugg MT; Bruderer T; García-Gómez D; Moeller A; Singer F; Schwarz EI; Benden C; M-L Sinues P; Zenobi R; Kohler M
    J Breath Res; 2018 Apr; 12(3):036013. PubMed ID: 29555894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of chondrosarcoma in a noninvasive way using volatile organic compounds in exhaled breath: a pilot study.
    Evenhuis RE; Acem I; van Praag VM; van der Wal RJ; Bus MP; van de Sande MA
    Future Oncol; 2024; 20(22):1545-1552. PubMed ID: 38864668
    [No Abstract]   [Full Text] [Related]  

  • 32. Human volatilome analysis using eNose to assess uncontrolled asthma in a clinical setting.
    Farraia M; Cavaleiro Rufo J; Paciência I; Castro Mendes F; Rodolfo A; Rama T; Rocha SM; Delgado L; Brinkman P; Moreira A
    Allergy; 2020 Jul; 75(7):1630-1639. PubMed ID: 31997360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
    Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children.
    Dallinga JW; Robroeks CM; van Berkel JJ; Moonen EJ; Godschalk RW; Jöbsis Q; Dompeling E; Wouters EF; van Schooten FJ
    Clin Exp Allergy; 2010 Jan; 40(1):68-76. PubMed ID: 19793086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
    Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
    J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy.
    Abdel-Aziz MI; Brinkman P; Vijverberg SJH; Neerincx AH; de Vries R; Dagelet YWF; Riley JH; Hashimoto S; Montuschi P; Chung KF; Djukanovic R; Fleming LJ; Murray CS; Frey U; Bush A; Singer F; Hedlin G; Roberts G; Dahlén SE; Adcock IM; Fowler SJ; Knipping K; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH; ;
    J Allergy Clin Immunol; 2020 Nov; 146(5):1045-1055. PubMed ID: 32531371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breath analysis in detecting epilepsy.
    van Dartel D; Schelhaas HJ; Colon AJ; Kho KH; de Vos CC
    J Breath Res; 2020 Apr; 14(3):031001. PubMed ID: 31972555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.